Kenji Ohtsubo
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
-
- Pharmacological Effects and Toxicity Studies 7
- Pharmacology top 10%
-
- Epilepsy research and treatment 5
-
- Analytical Chemistry and Chromatography 4
-
- Amino Acid Enzymes and Metabolism 2
-
- Myasthenia Gravis and Thymoma 2
-
- Nitric Oxide and Endothelin Effects 2
-
- Metabolism and Genetic Disorders 2
- Co-authors
- Ichiro IeiriMasaya ItodaHiroshi SuzukiShogo OzawaYuichi SugiyamaJun-ichi SawadaKazunori MineChihiro Kondo
- Partner nations
- JapanNew ZealandSouth Korea
In The Last Decade
Kenji Ohtsubo
24 papers receiving 461 citations
Peers
Comparison fields: 5 of 71
- Oncology 292
- Pediatrics, Perinatology and Child Health 194
- Pharmacology 64
- Transplantation 14
- Psychiatry and Mental health 58
Countries citing papers authored by Kenji Ohtsubo
This map shows the geographic impact of Kenji Ohtsubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ohtsubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ohtsubo more than expected).
Fields of papers citing papers by Kenji Ohtsubo
This network shows the impact of papers produced by Kenji Ohtsubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ohtsubo. The network helps show where Kenji Ohtsubo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenji Ohtsubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 6 | |
| 2 | 2004 | 213 | |
| 3 | 2004 | 91 | |
| 4 | 1995 | 4 | |
| 5 | 1995 | 10 | |
| 6 | 1995 | 20 | |
| 7 | 1994 | 21 | |
| 8 | 1994 | 4 | |
| 9 | 1992 | 8 | |
| 10 | 1991 | 1 | |
| 11 | 1990 | 2 | |
| 12 | [Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-lipiodol suspension in a child with hepatoblastoma]. | 1990 | 1 |
| 13 | 1989 | 7 | |
| 14 | 1989 | 5 | |
| 15 | 1988 | 14 | |
| 16 | 1986 | 5 | |
| 17 | 1982 | 8 | |
| 18 | 1980 | 4 | |
| 19 | 1979 | 8 | |
| 20 | 1978 | 2 |
About Kenji Ohtsubo
Kenji Ohtsubo is a scholar working on Pediatrics, Perinatology and Child Health, Process Chemistry and Technology and Psychiatry and Mental health, having authored 24 papers that have together received 483 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (7 papers), Epilepsy research and treatment (5 papers), Analytical Chemistry and Chromatography (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Myasthenia Gravis and Thymoma (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Oncology (292 citations), Pediatrics, Perinatology and Child Health (194 citations) and Pharmacology (64 citations). Kenji Ohtsubo has collaborated with scholars based in Japan, New Zealand and South Korea. Frequent co-authors include Ichiro Ieiri, Masaya Itoda, Hiroshi Suzuki, Shogo Ozawa, Yuichi Sugiyama, Jun-ichi Sawada, Kazunori Mine, Chihiro Kondo, Daisuke Kobayashi and Yosuke Ohkura. Their work appears in journals such as Analytica Chimica Acta, Pharmaceutical Research and Epilepsia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.